483 related articles for article (PubMed ID: 26589516)
1. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
2. Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.
Śpiewak M; Kłopotowski M; Gawor M; Kubik A; Kowalik E; Miłosz-Wieczorek B; Dąbrowski M; Werys K; Mazurkiewicz Ł; Kożuch K; Polańska-Skrzypczyk M; Petryka-Mazurkiewicz J; Klisiewicz A; Bilińska ZT; Grzybowski J; Witkowski A; Marczak M
J Cardiovasc Magn Reson; 2017 Dec; 19(1):105. PubMed ID: 29268761
[TBL] [Abstract][Full Text] [Related]
3. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
[TBL] [Abstract][Full Text] [Related]
4. Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction.
Zhong Y; Li C; Yu Y; Du Y; Bai Y; Wang X; Dai X; Fan G; Wang G
Int J Cardiovasc Imaging; 2024 Apr; 40(4):921-930. PubMed ID: 38448705
[TBL] [Abstract][Full Text] [Related]
5. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.
Dimitrow PP; Grodecki J; Bacior B; Dudek D; Legutko J; Jaszcz KK; Dubiel JS
Pacing Clin Electrophysiol; 2000 Sep; 23(9):1324-9. PubMed ID: 11025886
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
[TBL] [Abstract][Full Text] [Related]
7. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
8. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
Zhi Y; Gui FD; Xue M; Long YT; Miao W; Yi Y; Gao LC; Bing F; Pan SY
BMC Cardiovasc Disord; 2024 Apr; 24(1):203. PubMed ID: 38594610
[TBL] [Abstract][Full Text] [Related]
9. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
10. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
11. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
12. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
[TBL] [Abstract][Full Text] [Related]
13. Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis.
Steen H; Giusca S; Montenbruck M; Patel AR; Pieske B; Florian A; Erley J; Kelle S; Korosoglou G
J Cardiovasc Magn Reson; 2021 Apr; 23(1):45. PubMed ID: 33823860
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging.
White RD; Obuchowski NA; Gunawardena S; Lipchik EO; Lever HM; Van Dyke CW; Lytle BW
Am J Card Imaging; 1996 Jan; 10(1):1-13. PubMed ID: 8680128
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy.
Ku MC; Kober F; Lai YC; Pohlmann A; Qadri F; Bader M; Carrier L; Niendorf T
J Cardiovasc Magn Reson; 2021 May; 23(1):63. PubMed ID: 34053450
[TBL] [Abstract][Full Text] [Related]
17. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
Fluechter S; Kuschyk J; Wolpert C; Doesch C; Veltmann C; Haghi D; Schoenberg SO; Sueselbeck T; Germans T; Streitner F; Borggrefe M; Papavassiliu T
J Cardiovasc Magn Reson; 2010 May; 12(1):30. PubMed ID: 20492668
[TBL] [Abstract][Full Text] [Related]
18. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
[TBL] [Abstract][Full Text] [Related]
19. Transient bradycardia induced by carotid sinus pressure increases outflow obstruction in hypertrophic obstructive cardiomyopathy but not in valvular aortic stenosis.
Klein HO; Keren G; Bakst A; Laniado S; Lang R; Kaplinsky E; Di Segni E
Chest; 1998 Aug; 114(2):469-76. PubMed ID: 9726732
[TBL] [Abstract][Full Text] [Related]
20. Machine learning evaluation of LV outflow obstruction in hypertrophic cardiomyopathy using three-chamber cardiovascular magnetic resonance.
Sahota M; Saraskani SR; Xu H; Li L; Majeed AW; Hermida U; Neubauer S; Desai M; Weintraub W; Desvigne-Nickens P; Schulz-Menger J; Kwong RY; Kramer CM; Young AA; Lamata P;
Int J Cardiovasc Imaging; 2022 Dec; 38(12):2695-2705. PubMed ID: 36201099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
